improving risk stratification & treatment decisions for dlbcl: ctdna & the ipi
Published 11 months ago • 131 plays • Length 2:10Download video MP4
Download video MP3
Similar videos
-
3:24
improving risk stratification in all with risk scores & genomic studies to personalize therapy
-
1:40
utilizing ai for individualized treatment-adjusted risk stratification in newly diagnosed myeloma
-
3:04
applying molecular understanding of dlbcl to management strategies
-
0:42
targeted therapies for dlbcl treatment
-
1:02:24
technique talk: improving ihc and if staining results
-
27:27
mdr tb drug regimens and management guidelines simplified | mdr tb management in special situations
-
14:27
ukpds and dcct/edic trial review
-
1:47
shared treatment decision-making
-
1:17
mrd measurement as a strategy for treatment-free survival
-
2:16
correcting the function of mutated hemoglobin with gene therapy for scd
-
1:05
the importance of using mrd to guide treatment decisions in all
-
1:41
using cytogenetics to improve the diagnosis and prognosis of mds & to predict response to treatment
-
0:52
advances in treatment modalities to reduce the risk of gvhd in allografted patients
-
1:41
transplant optimization strategies
-
1:28
how the standard of care for dlbcl is changing with the introduction of novel agents
-
1:35
maintenance & consolidation strategies for all and their impact on qol
-
0:47
overview of the phase iii enhance trial schema
-
1:48
optimizing the efficacy of t-cell based immunotherapies
-
0:59
developing lsc-targeting agents in aml: progress and current therapeutic capacity
-
2:38
zuma-1 & scholar-1: comparison of outcomes in refractory dlbcl
-
1:00
proof of principle to progress treatments